Palmitoleic acid prevents palmitic acid-induced macrophage activation and consequent p38 MAPK-mediated skeletal muscle insulin resistance

Molecular and Cellular Endocrinology

Volumn 393, Issue 1-2, 2014, Pages 129-142

  Talbot, Nicola A ^a   Wheeler Jones, Caroline P ^a   Cleasby, Mark E ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Fatty acid; Insulin resistance; Macrophage; P38 Mitogen activated protein kinase; Skeletal muscle; Tumour necrosis factor

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; PALMITIC ACID; PALMITOLEIC ACID; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; MONOUNSATURATED FATTY ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLYCOGEN SYNTHESIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MACROPHAGE ACTIVATION; MACROPHAGE CULTURE; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; REAL TIME POLYMERASE CHAIN REACTION;

CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS, MONOUNSATURATED; HUMANS; INSULIN RESISTANCE; MACROPHAGE ACTIVATION; MUSCLE, SKELETAL; MYOBLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PALMITIC ACID; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84930711285     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.06.010     Document Type: Article

References (65)

1. Aguirre V., Werner E.D., Giraud J., Lee Y.H., Shoelson S.E., White M.F. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 2002, 277:1531-1537. 10.1074/jbc.M101521200.
2. Antonescu C.N., Huang C., Niu W., Liu Z., Eyers P.A., Heidenreich K.A., Bilan P.J., Klip A. Reduction of insulin-stimulated glucose uptake in L6 myotubes by the protein kinase inhibitor SB203580 is independent of p38MAPK activity. Endocrinology 2005, 146:3773-3781. 10.1210/en.2005-0404.
3. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., McLauchlan H., Klevernic I., Arthur J.S., Alessi D.R., Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 2007, 408:297-315. 10.1042/BJ20070797.
4. Boppart M.D., Asp S., Wojtaszewski J.F., Fielding R.A., Mohr T., Goodyear L.J. Marathon running transiently increases c-Jun NH2-terminal kinase and p38 activities in human skeletal muscle. J. Physiol. 2000, 526(Pt 3):663-669. 10.1111/j.1469-7793.2000.00663.x.
5. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., Coupaye M., Pelloux V., Hugol D., Bouillot J.L., Bouloumie A., Barbatelli G., Cinti S., Svensson P.A., Barsh G.S., Zucker J.D., Basdevant A., Langin D., Clement K. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005, 54:2277-2286. 10.2337/diabetes.54.8.2277.
6. Cao H., Gerhold K., Mayers J.R., Wiest M.M., Watkins S.M., Hotamisligil G.S. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008, 134:933-944. 10.1016/j.cell.2008.07.048.
7. Carlson C.J., Rondinone C.M. Pharmacological inhibition of p38 MAP kinase results in improved glucose uptake in insulin-resistant 3T3-L1 adipocytes. Metabolism 2005, 54:895-901. 10.1016/j.metabol.2005.02.003.
8. Cazzolli R., Carpenter L., Biden T.J., Schmitz-Peiffer C. A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate. Diabetes 2001, 50:2210-2218. 10.2337/diabetes.50.10.2210.
9. Chavez J.A., Summers S.A. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch. Biochem. Biophys. 2003, 419:101-109.
10. Cleasby M.E., Reinten T.A., Cooney G.J., James D.E., Kraegen E.W. Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression. Mol. Endocrinol. 2007, 21:215-228. 10.1210/me.2006-0154.
11. Coll T., Eyre E., Rodriguez-Calvo R., Palomer X., Sanchez R.M., Merlos M., Laguna J.C., Vazquez-Carrera M. Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. J. Biol. Chem. 2008, 283:11107-11116. 10.1074/jbc.M708700200.
12. Corraliza I.M., Campo M.L., Soler G., Modolell M. Determination of arginase activity in macrophages: a micromethod. J. Immunol. Methods 1994, 174:231-235. 10.1016/0022-1759(94)90027-2.
13. de Alvaro C., Teruel T., Hernandez R., Lorenzo M. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J. Biol. Chem. 2004, 279:17070-17078. 10.1074/jbc.M312021200.
14. De Paepe B., Creus K.K., Martin J.J., De Bleecker J.L. Upregulation of chemokines and their receptors in Duchenne muscular dystrophy: potential for attenuation of myofiber necrosis. Muscle Nerve 2012, 46:917-925. 10.1002/mus.23481.
15. Devaraj S., Venugopal S.K., Singh U., Jialal I. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}. Diabetes 2005, 54:85-91.
16. Diamond-Stanic M.K., Marchionne E.M., Teachey M.K., Durazo D.E., Kim J.S., Henriksen E.J. Critical role of the transient activation of p38 MAPK in the etiology of skeletal muscle insulin resistance induced by low-level in vitro oxidant stress. Biochem. Biophys. Res. Commun. 2011, 405:439-444. 10.1016/j.bbrc.2011.01.049.
17. Dimopoulos N., Watson M., Sakamoto K., Hundal H.S. Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells. Biochem. J. 2006, 399:473-481. 10.1042/BJ20060244.
18. Elgazar-Carmon V., Rudich A., Hadad N., Levy R. Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J. Lipid Res. 2008, 49:1894-1903. 10.1194/jlr.M800132-JLR200.
19. Festa A., D'Agostino R., Tracy R.P., Haffner S.M. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002, 51:1131-1137. 10.2337/diabetes.51.4.1131.
20. Fink L.N., Oberbach A., Costford S.R., Chan K.L., Sams A., Bluher M., Klip A. Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes. Diabetologia 2013, 56:1623-1628. 10.1007/s00125-013-2897-x.
21. Fujishiro M., Gotoh Y., Katagiri H., Sakoda H., Ogihara T., Anai M., Onishi Y., Ono H., Abe M., Shojima N., Fukushima Y., Kikuchi M., Oka Y., Asano T. Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes. Mol. Endocrinol. 2003, 17:487-497. 10.1210/me.2002-0131.
22. Gao D., Griffiths H.R., Bailey C.J. Oleate protects against palmitate-induced insulin resistance in L6 myotubes. Br. J. Nutr. 2009, 102:1557-1563. 10.1017/s0007114509990948.
23. Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., Goodyear L.J., Kraegen E.W., White M.F., Shulman G.I. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999, 48:1270-1274. 10.2337/diabetes.48.6.1270.
24. Haversen L., Danielsson K.N., Fogelstrand L., Wiklund O. Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis 2009, 202:382-393. 10.1016/j.atherosclerosis.2008.05.033.
25. Hemi R., Yochananov Y., Barhod E., Kasher-Meron M., Karasik A., Tirosh A., Kanety H. P38 mitogen-activated protein kinase-dependent transactivation of ErbB receptor family: a novel common mechanism for stress-induced IRS-1 serine phosphorylation and insulin resistance. Diabetes 2011, 60:1134-1145. 10.2337/db09-1323.
26. Hevener A.L., Olefsky J.M., Reichart D., Nguyen M.T., Bandyopadyhay G., Leung H.Y., Watt M.J., Benner C., Febbraio M.A., Nguyen A.K., Folian B., Subramaniam S., Gonzalez F.J., Glass C.K., Ricote M. Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J. Clin. Invest. 2007, 117:1658-1669. 10.1172/JCI31561.
27. Hirabara S.M., Curi R., Maechler P. Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells. J. Cell. Physiol. 2010, 222:187-194. 10.1002/jcp.21936.
28. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., Karin M., Hotamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336. 10.1038/nature01137.
29. Hoehn K.L., Hohnen-Behrens C., Cederberg A., Wu L.E., Turner N., Yuasa T., Ebina Y., James D.E. IRS1-independent defects define major nodes of insulin resistance. Cell Metab. 2008, 7:421-433. 10.1016/j.cmet.2008.04.005.
30. Hommelberg P.P., Plat J., Sparks L.M., Schols A.M., van Essen A.L., Kelders M.C., van Beurden D., Mensink R.P., Langen R.C. Palmitate-induced skeletal muscle insulin resistance does not require NF-kappaB activation. Cell. Mol. Life Sci. 2011, 68:1215-1225. 10.1007/s00018-010-0515-3.
31. Hotamisligil G.S., Budavari A., Murray D., Spiegelman B.M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J. Clin. Invest. 1994, 94:1543-1549. 10.1172/jci117495.
32. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91. 10.1126/science.7678183.
33. Hwang D. Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways. Faseb J. 2001, 15:2556-2564. 10.1096/fj.01-0432com.
34. Kadotani A., Tsuchiya Y., Hatakeyama H., Katagiri H., Kanzaki M. Different impacts of saturated and unsaturated free fatty acids on COX-2 expression in C(2)C(12) myotubes. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E1291-E1303. 10.1152/ajpendo.00293.2009.
35. Karten B., Boechzelt H., Abuja P.M., Mittelbach M., Sattler W. Macrophage-enhanced formation of cholesteryl ester-core aldehydes during oxidation of low density lipoprotein. J. Lipid Res. 1999, 40:1240-1253.
36. Kewalramani G., Fink L.N., Asadi F., Klip A. Palmitate-activated macrophages confer insulin resistance to muscle cells by a mechanism involving protein kinase C theta and epsilon. PLoS One 2011, 6:e26947. 10.1371/journal.pone.0026947.
37. Kuma Y., Sabio G., Bain J., Shpiro N., Marquez R., Cuenda A. BIRB796 inhibits all p38 MAPK isoforms in vitro and in vivo. J. Biol. Chem. 2005, 280:19472-19479. 10.1074/jbc.M414221200.
38. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 2001, 276:16683-16689. 10.1074/jbc.M011695200.
39. Lee J.Y., Zhao L., Youn H.S., Weatherill A.R., Tapping R., Feng L., Lee W.H., Fitzgerald K.A., Hwang D.H. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J. Biol. Chem. 2004, 279:16971-16979. 10.1074/jbc.M312990200.
40. Liang H., Yin B., Zhang H., Zhang S., Zeng Q., Wang J., Jiang X., Yuan L., Wang C.Y., Li Z. Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-alpha signaling protected Wistar rats from diet-induced obesity and insulin resistance. Endocrinology 2008, 149:2943-2951. 10.1210/en.2007-0978.
41. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 2007, 117:175-184. 10.1172/JCI29881.
42. Lumeng C.N., Deyoung S.M., Bodzin J.L., Saltiel A.R. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007, 56:16-23. 10.2337/db06-1076.
43. Maekawa T., Jin W., Ishii S. The role of ATF-2 family transcription factors in adipocyte differentiation: antiobesity effects of p38 inhibitors. Mol. Cell. Biol. 2010, 30:613-625. 10.1128/mcb.00685-09.
44. McCall K.D., Holliday D., Dickerson E., Wallace B., Schwartz A.L., Schwartz C., Lewis C.J., Kohn L.D., Schwartz F.L. Phenylmethimazole blocks palmitate-mediated induction of inflammatory cytokine pathways in 3T3L1 adipocytes and RAW 264.7 macrophages. J. Endocrinol. 2010, 207:343-353. 10.1677/joe-09-0370.
45. Nguyen M.T., Favelyukis S., Nguyen A.K., Reichart D., Scott P.A., Jenn A., Liu-Bryan R., Glass C.K., Neels J.G., Olefsky J.M. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 2007, 282:35279-35292. 10.1074/jbc.M706762200.
46. Patel S.A., Hoehn K.L., Lawrence R.T., Sawbridge L., Talbot N.A., Tomsig J.L., Turner N., Cooney G.J., Whitehead J.P., Kraegen E.W., Cleasby M.E. Overexpression of the adiponectin receptor AdipoR1 in rat skeletal muscle amplifies local insulin sensitivity. Endocrinology 2012, 153:5231-5246. 10.1210/en.2012-1368.
47. Pillon N.J., Arane K., Bilan P.J., Chiu T.T., Klip A. Muscle cells challenged with saturated fatty acids mount an autonomous inflammatory response that activates macrophages. Cell Commun. Signal. 2012, 10:30. 10.1186/1478-811x-10-30.
48. Pinnick K.E., Neville M.J., Fielding B.A., Frayn K.N., Karpe F., Hodson L. Gluteofemoral adipose tissue plays a major role in production of the lipokine palmitoleate in humans. Diabetes 2012, 61:1399-1403. 10.2337/db11-1810.
49. Plomgaard P., Bouzakri K., Krogh-Madsen R., Mittendorfer B., Zierath J.R., Pedersen B.K. Tumor Necrosis Factor-{alpha} Induces Skeletal Muscle Insulin Resistance in Healthy Human Subjects via Inhibition of Akt substrate 160 Phosphorylation. Diabetes 2005, 54:2939-2945. 10.2337/diabetes.54.10.2939.
50. Polkinghorne E., Lau Q., Cooney G.J., Kraegen E.W., Cleasby M.E. Local activation of the IκK-NFκB pathway in muscle does not cause insulin resistance. Am. J. Physiol Endocrinol. Metab. 2008, 294:E316-E325. 10.1152/ajpendo.00537.2007.
51. Prieur X., Mok C.Y., Velagapudi V.R., Nunez V., Fuentes L., Montaner D., Ishikawa K., Camacho A., Barbarroja N., O'Rahilly S., Sethi J.K., Dopazo J., Oresic M., Ricote M., Vidal-Puig A. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes 2011, 60:797-809. 10.2337/db10-0705.
52. Samokhvalov V., Bilan P.J., Schertzer J.D., Antonescu C.N., Klip A. Palmitate and lipopolysaccharide-activated macrophages evoke contrasting insulin responses in muscle cells. Am. J. Physiol. Endocrinol. Metab. 2008, 296:E37-E46. 10.1152/ajpendo.90667.2008.
53. Schilling J.D., Machkovech H.M., He L., Sidhu R., Fujiwara H., Weber K., Ory D.S., Schaffer J.E. Palmitate and lipopolysaccharide trigger synergistic ceramide production in primary macrophages. J. Biol. Chem. 2013, 288:2923-2932. 10.1074/jbc.M112.419978.
54. Sell H., Dietze-Schroeder D., Kaiser U., Eckel J. Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 2006, 147:2458-2467. 10.1210/en.2005-0969.
55. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 116:3015-3025. 10.1172/JCI28898.
56. Solinas G., Naugler W., Galimi F., Lee M.S., Karin M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc. Natl. Acad. Sci. USA 2006, 103:16454-16459. 10.1073/pnas.0607626103.
57. Storlien L.H., Jenkins A.B., Chisholm D.J., Pascoe W.S., Khouri S., Kraegen E.W. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991, 40:280-289. 10.2337/diab.40.2.280.
58. Suganami T., Nishida J., Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2062-2068. 10.1161/01.atv.0000183883.72263.13.
59. Tardif N., Salles J., Landrier J.F., Mothe-Satney I., Guillet C., Boue-Vaysse C., Combaret L., Giraudet C., Patrac V., Bertrand-Michel J., Migne C., Chardigny J.M., Boirie Y., Walrand S. Oleate-enriched diet improves insulin sensitivity and restores muscle protein synthesis in old rats. Clin. Nutr. 2011, 30:799-806. 10.1016/j.clnu.2011.05.009.
60. Thong F.S., Bilan P.J., Klip A. The rab GTPase-activating protein AS160 integrates Akt, protein kinase C, and AMP-activated protein kinase signals regulating GLUT4 traffic. Diabetes 2007, 56:414-423.
61. Turner N., Cooney G.J., Kraegen E.W., Bruce C.R. Fatty acid metabolism, energy expenditure and insulin resistance in muscle. J. Endocrinol. 2014, 220:T61-T79. 10.1530/joe-13-0397.
62. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389:610-614. 10.1038/39335.
63. Varma V., Yao-Borengasser A., Rasouli N., Nolen G.T., Phanavanh B., Starks T., Gurley C., Simpson P., McGehee R.E., Kern P.A., Peterson C.A. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E1300-E1310. 10.1152/ajpendo.90885.2008.
64. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808. 10.1172/JCI19246.
65. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W., Karin M., Shoelson S.E. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001, 293:1673-1677. 10.1126/science.1061620.